# Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study

> **NCT07522762** · — · RECRUITING · sponsor: **The Netherlands Cancer Institute** · enrollment: 330 (estimated)

## Conditions studied

- Gastrointenstinal Stromal Tumor (GIST)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07522762
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-21
- **Primary completion:** 2027-05-21
- **Final completion:** 2037-05-21
- **Target enrollment:** 330 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07522762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07522762, "Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07522762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*